XML 38 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 18 - Stock-based Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
1
8
– STOCK-BASED COMPENSATION
 
Stock-based expense for the years ended
December 31, 2018
and
2017,
were
$487,000
and
$25,000
of which
$354,000
and
$16,000
was charged to stock-based compensation expense and
$133,000
and
$9,000
was charged to stock-based other noninterest expense, respectively.
 
On
November 17, 2017
the stockholders approved the adoption of the
2017
Equity Incentive Plan (“Incentive Plan”). The Incentive Plan provides for the grant of a maximum of
263,127
shares of the Company’s common stock of which up to
187,948
shares of common stock
may
be granted for stock options and
75,179
shares of common stock
may
be issued as restricted stock to Directors and employees of the Company.
 
On
February 27, 2018
the Company awarded options to purchase
5,000
shares of the Company’s common stock and issued
439
shares of restricted stock. All stock option awards were granted with an exercise price equal to the grant date closing price of the Company’s common stock of
$15.48
per share. Stock options and restricted stock awards under the Incentive Plan vest at
20%
per year beginning on the
first
university of date of grant and have a maximum term of
seven
years.
 
The grant-date fair value of stock option awards granted on
February 27, 2018
was
$4.04
using the Black Scholes Merton options pricing model with the following inputs and assumptions:
 
Grant date stock price
  $
15.48
 
Dividend yield
   
0.00
%
Expected volatility
   
19.55
%
Risk-free interest rate
   
2.75
%
Expected life in years
   
6
 
 
The Company also has vested and outstanding stock options issued under the
2001
Stock Option Plan (“Prior Plan”).
No
options were granted under the Prior Plan in
2018
or
2017
and
no
further options can be granted under this plan. There was
no
stock-based compensation expense under this plan in
2018
or
2017.
 
The expected volatility represents the average volatility of a peer group of financial institutions that had
2
nd
step conversions prior to the company’s
2016
conversion. Historical data is used to estimate the term of options expected to be outstanding and takes into account that options are
not
transferable. The risk-free interest rate is based on the U.S. Treasury yield curve for the expected term in effect at the date of grant.
 
A summary of stock option activity during the years ended
December 31, 2018
and
2017
is presented below:
 
   
For the Year Ended December 31, 2018
 
   
 
 
 
 
 
 
 
 
Average
 
   
 
 
 
 
Weighted-
   
Remaining
 
   
 
 
 
 
Average
   
Contractual
 
   
Shares
   
Exercise Price
   
Term (years)
 
                         
Outstanding, December 31, 2017
 
 
207,108
   
$
14.18
   
 
6.2
 
Granted
 
 
5,000
   
 
15.48
   
 
-
 
Exercised
 
 
(15,464
)
 
 
9.65
   
 
-
 
Forfeited or expired
 
 
(32,234
)
 
 
13.98
   
 
-
 
                         
Outstanding, December 31, 2018
 
 
164,410
   
$
14.68
   
 
5.8
 
                         
Exercisable, December 31, 2018
 
 
37,890
   
$
13.89
   
 
4.9
 
 
 
   
For the Year Ended December 31, 2017
 
                   
Average
 
     
 
   
Weighted-
   
Remaining
 
     
 
   
Average
   
Contractual
 
   
Shares
   
Exercise Price
   
Term (years)
 
                         
Outstanding, December 31, 2016
   
34,190
    $
9.65
     
2.3
 
Granted
   
178,650
     
14.9
0
     
6.9
 
Exercised
   
(5,732
)    
9.
65
     
-
 
Forfeited or expired
   
-
     
-
     
-
 
                         
Outstanding, December 31, 2017
   
207,108
    $
14.18
     
6.2
 
                         
Exercisable, December 31, 2017
   
28,458
    $
9.65
     
1.3
 
 
Information related to stock options during each year is as follows:
 
   
Year Ended December 31,
 
   
2018
   
2017
 
                 
Intrinsic value of options exercised
 
$
89,080
    $
25,909
 
Cash received from option exercises
 
$
149,228
    $
55,314
 
Tax benefit from option exercises
 
$
24,866
    $
21,240
 
Total weighted average fair value of options granted
 
$
20,200
    $
653,859
 
 
 
A summary of restricted stock activity during the years ended
December 31, 2018
and
2017
is presented below:
 
           
Weighted
   
Average
 
           
Avererage
   
Remaining
 
           
Grant Date
   
Contractual
 
   
Shares
   
Price
   
Term (years)
 
                         
   
For the Year Ended December 31, 2018
 
                         
Outstanding, December 31, 2017
 
 
74,750
   
$
14.90
   
 
4.9
 
                         
Granted
 
 
429
   
$
15.48
   
 
 
 
Vested
 
 
(18,850
)
 
 
14.90
   
 
 
 
Forfeited or expired
 
 
(6,500
)
 
 
14.90
   
 
 
 
                         
Outstanding, December 31, 2018
 
 
49,829
   
$
14.90
   
 
4.0
 
 
   
For the Year Ended December 31, 2017
 
                         
Outstanding, December 31, 2016
   
-
     
 
     
 
 
                         
Granted
   
74,750
    $
14.90
     
 
 
Vested
   
-
     
 
     
 
 
Forfeited or expired
   
-
     
 
     
 
 
                         
Outstanding, December 31, 2017
   
74,750
    $
14.90
     
4.9
 
 
 
As of
December 31, 2018,
there was
$461,000
and
$723,000
of total unrecognized equity-based expense related to unvested stock options and restricted stock awards granted under the
2017
Equity Incentive Plan, respectively, that is expected to be recognized over a weighted average period of
4
years.